tiprankstipranks
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market

Compare Qyuns Therapeutics Co., Ltd. Class H (2509) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Qyuns Therapeutics Co., Ltd. Class H
HK$28.58
HK$4.66B
12.32
128.67%
3 Buy
0 Hold
0 Sell
Strong Buy
Antengene Corporation Limited
HK$5.27
HK$3.56B
-3.61
116.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genor Biopharma Holdings Limited
HK$3.06
HK$6.04B
2.00
52.00%
Jacobio Pharmaceuticals Group Co., Ltd.
HK$7.05
HK$5.68B
-31.16
129.64%
2 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
54.35%
2 Buy
0 Hold
0 Sell
Moderate Buy
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.87B
-10.14
3.07%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2509
Qyuns Therapeutics Co., Ltd. Class H
18.98
10.68
128.67%
HK:6996
Antengene Corporation Limited
5.79
3.08
113.65%
HK:6998
Genor Biopharma Holdings Limited
3.04
0.89
41.40%
HK:1167
Jacobio Pharmaceuticals Group Co., Ltd.
7.05
3.68
109.20%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.80
6.10
48.03%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
5.38
-0.22
-3.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts